This notion is also supported by the genetic evidence that mutations in cationic trypsinogen (PRSS1), pancreatic secretory trypsin inhibitor (SPINK1), and chymotrypsinogen C (CTRC) are associated with the susceptibility of pancreatitis [157]. The gene discussed is CTRC; the disease is pancreatitis.